Titan Spine enters distribution agreement to expand implant portfolio in Europe
Titan Spine announced in September that it has entered into a distribution agreement with MBA as a strategic partner to provide Titan’s line of Endoskeleton® titanium implants to practising spine surgeons in Spain, Portugal, Andorra, Luxembourg, Belgium and the UK. MBA is a medical device marketing and distribution organisation that specialises in the sale of products used for orthopaedic and neurosurgery treatments.
“Partnering with Titan Spine to distribute the Endoskeleton line of interbody fusion devices enables us to significantly enhance our offering of spinal products, and further makes innovative implants, that meet the needs and, ultimately, create value for the surgeons and their patients, more accessible,” said Paul Griffin, managing director at MBA.
In addition, Titan Spine recently opened an office in Valencia, Spain, to support the growing European adoption of its Endoskeleton devices. The Spain office supports sales, training and marketing initiatives across Europe in conjunction with Titan’s European headquarters located in Laichingen, Germany.
Kevin Gemas, president of Titan Spine, said: “Titan Spine has experienced significant sales growth over the last few years, particularly over the first half of 2015. By broadly expanding our line of titanium spinal implants to surgeons and patients in six additional countries across Europe, we have a greater opportunity to offer the benefits of our subtractive surface technology for surgeons and patients in Europe. We are seeing growing European demand for surface-enhanced interbody fusion devices that do not possess the potential hazards associated with additive/coated implants.”
Source: BusinessWire
